18.02.2021 • NewsRepsol

Repsol Licenses Technologies to China

Spanish energy and petrochemical group Repsol has signed a licensing agreement for its propylene oxide/styrene monomer (PO/SM) and polyols technologies for three plants in China.

Under the terms of the license, Repsol will supply processes for plants producing 200,000 t/y PO and 450,000 t/y SM, as well as two plants with an aggregated capacity of 125,000 t/y of both flexible and polymer polyether polyols. The plants are being built in Jiangsu province but the identity of the Chinese producer was not disclosed.

Repsol added that it plans to continue collaborating with the licensee on further initiatives to strengthen its position in the Chinese market.

This latest agreement is the third in China that Repsol has entered into since 2013. In January 2017, the Spanish company signed a licensing deal with Tianjin Bohua Chemical Development for plants producing 200,000 t/y of PO and 450,000 t/y of SM.

An agreement in 2013 was for a 400,000 t/y flexible and polymer polyols facility in Jilin province.

Author: Elaine Burridge, Freelance Journalist

Repsol has signed a licensing agreement for its propylene oxide/styrene monomer...
Repsol has signed a licensing agreement for its propylene oxide/styrene monomer (PO/SM) and polyols technologies in China. The Spanish firm’s processes will be used in plants producing 200,000 t/y PO and 450,000 t/y SM, and two plants producing 125,000 t/y of polyether polyols. (c) Repsol

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.